26th Hong Kong Medical Forum

14 May 2022 - 15 May 2022

Secondary immunodeficiency common yet underdiagnosed and undertreated in HK

07 Jun 2022 by

Local data presented at the 26^th HKMF indicates that secondary immunodeficiency (SID), a common disease that can be treated with immunoglobulin (Ig) replacement therapy, is underdiagnosed and undertreated in Hong Kong.

07 Jun 2022

Adding spironolactone or sacubitril/valsartan to empagliflozin suggested for a wide spectrum of symptomatic HFpEF

27 May 2022 by

Spironolactone and sacubitril/valsartan are potential add-on therapies to empagliflozin for a wide spectrum of symptomatic heart failure with preserved ejection fraction (HFpEF), according to an evidence-based treatment algorithm presented at the 26^th Hong Kong Medical Forum.

27 May 2022

COVID-19 vaccine booster efficacy: What do new HK data show?

23 May 2022 by

A booster dose of the mRNA-based BNT162b2 vaccine provides more robust antibody responses to SARS-CoV-2, including the Omicron BA.1 and BA.2 variants, than the inactivated CZ02 vaccine, but three doses of either vaccine are equally effective in reducing the risk of severe or fatal COVID-19, according to new local data presented at the 26th Hong Kong Medical Forum (HKMF).

23 May 2022